Cure rate of low-risk superficial basal cell carcinoma treated with topical 5-fluorouracil
Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica · 30.07.2024 · 32 (3) · 253-261
DOI: 10.29176/2590843x.1834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica, online erschienen am 30.07.2024. Verfasst von Camilo E Alarcón Pérez und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Basal cell carcinoma (BCC) is the most common cancer in the world making this condition a public health issue. Superficial BCC (sBCC) is a subtype with indolent behavior. The gold standard treatment is the surgical resection, however, sBCC can be treated with more cost-effective noninvasive therapies such as 5% 5-Fluorouracil (5-FU). The objective of this study was to evaluate the clinical cure rate, tolerability and satisfaction levels on patients featured intermediate pigmented skin in the treatment of low-risk superficial basal cell carcinoma with topical 5% 5-FU.
Methods
A prospective case series study was conducted between June 2014 and August 2018 at the dermatology service of Hospital de San José in Bogotá, Colombia with histologically-proven superficial BCC lesions. Lesions were treated with topical 5% 5-FU twice daily for up to 8 weeks. A follow-up evaluation was conducted at weeks four and eight during treatment. Follow-up was planned to be conducted every three months.
Results
The study included 19 patients with 23 biopsy-proven sBCC lesions. Twenty-two lesions completed treatment with 5% 5-FU cream. The follow-up period ranged between 7 and 48 months and the median follow-up time was 38 months (IQR 21-48). All study patients featured intermediate or higher pigmented skin. Clinical cure was achieved in 95.45% of treated lesions.
Conclusions
The efficacy rate of 5% 5-FU for 8 weeks treatment for sBCC located in intermediate and low-risk areas was 95% offering high levels of patient satisfaction with an outstanding tolerability profile.
Zitieren
APA
Pérez, C. E. A., Ariza-Gómez, S. A., & Morales-Naranjo, S. D. (2024). Cure rate of low-risk superficial basal cell carcinoma treated with topical 5-fluorouracil. Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica, 32(3), 253-261. https://doi.org/10.29176/2590843x.1834
Vancouver
Pérez CEA, Ariza-Gómez SA, Morales-Naranjo SD. Cure rate of low-risk superficial basal cell carcinoma treated with topical 5-fluorouracil. Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica. 2024;32(3):253-261. doi:10.29176/2590843x.1834
BibTeX
@article{Prez2024,
author = {Pérez, Camilo E Alarcón and Ariza-Gómez, Santiago A. and Morales-Naranjo, Samuel D.},
title = {Cure rate of low-risk superficial basal cell carcinoma treated with topical 5-fluorouracil},
journal = {Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica},
year = {2024},
volume = {32},
number = {3},
pages = {253--261},
doi = {10.29176/2590843x.1834}
}
EUVIMED